ATLAS Market profile
Menu
Atlas · Symbols · ETFs · DECU

Atlas market file · Etf · United States

AllianzIM U.S. Equity Buffer15 Uncapped Dec ETFDECU

Last close
29.998
Change
+0.55%
96-bar range
26.13 – 30.095
As of
7 Aug 2026

AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF is an exchange-traded fund listed as DECU on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot BATS:DECU

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

30.213929.163228.112527.061826.01123 Mar01 Jun07 Aug

up candle   down candle

Latest close29.998
Day change+0.55%
Window high30.095
Window low26.13
96-bar change+12.35%
SnapshotDaily · 96 bars
As of2026-08-07 13:30 UTC

Weekly outlook: the last 89 weekly closes (+19.11% over the window).

30.282622.598402 Dec07 Aug

Source rail: Yahoo Finance chart API (DECU). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for DECU. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

DECU public profile

Company

Exchange-traded fund. AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF is connected to current market context, cited company sources and its retained research file.

Market

AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF trades as DECU on BATS. AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. DECU stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

The AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF-DECU to its friends, if it had any-launched with all the fanfare of a banker's PowerPoint slide deck dropped into a spam folder. The fund's name promises a magical fifteen-percent buffer against equity pain, but the SEC filing quietly reveals that this buffer is a buffered outcome tied to the Russell 2000's December expiration, not a perpetual force field against market gravity. The filing is less a prospectus and more a legal yoga manual: contort your returns within the rules or face the consequences. Meanwhile, the Nasdaq ticker page flickers with the cold comfort of liquidity data that tells you the fund exists, but not why the source directs readers to care. (source: SEC EDGAR fund search for...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF today

Open full report
DECU daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

DECU, the AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF, entered public trading with a mandate that sounds like a hedge-fund daydream and a fee structure that reads like a banker’s invoice. The fund promises a fifteen-percent buffer against equity losses, but only within a narrow window tied to the Russell 2000’s December expiration, turning what sounds like a market miracle into a seasonal carnival act that resets every year. The SEC’s EDGAR filing for DECU confirms the fund’s existence and legal skeleton, but the document is silent on holdings, which means the source requires readers to trust the wrapper without seeing the bones underneath.

The issuer’s marketing sells the idea of capped pain and uncapped gain, but the FINRA fund analyzer spells out the true cost: a 0.79% expense ratio that chips away at any buffer before the market has a chance to prove itself. The fund’s structure is a buffered outcome tied to a single calendar event, not a perpetual shield, which turns a once-a-year reset into the main event rather than a footnote. The Nasdaq ticker page confirms the fund trades, but offers no insight into liquidity depth or the identity of the basket it tracks.

The SEC filing lists DECU as a buffered outcome ETF referencing the Russell 2000, a small-cap index where fortunes swing on sentiment as much as fundamentals. The filing does not disclose top holdings or concentration limits, leaving investors to wonder which thirty or forty small-cap stocks are underwriting the buffer. The mandate’s December linkage means the fund’s performance is a function of both the index’s path and the calendar’s cruel timing, not the fund’s skill at stock-picking. The only certainty is that AllianzIM earns its fee regardless of how the year ends.

The Nasdaq page for DECU shows the ticker is live, but the data on spreads, volume, and intraday liquidity is either absent or stale. The fund’s existence is proven; its daily liquidity and fair-value mechanics are not. The FINRA analyzer confirms the fee but cannot reveal how the buffer behaves in stress because the mechanism is locked to a single December reset. The fund’s structure is a legal time capsule that opens on a fixed date, not a dynamic toolkit for investors to deploy.

What remains unproven is whether DECU’s fifteen-percent buffer is worth the 0.79% annual vig, especially when the Russell 2000’s volatility can shred the benefit in a single bad quarter. The fund’s marketing is glossy; the rules are rigid; the holdings are a mystery. Until the SEC filing or issuer updates disclose the basket or the fund’s performance in varied markets, DECU remains a ticker in search of a story.

Sources & evidence · 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
DECU
Exchange
BATS
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

DECU technical readout

Trend strength (ADX 14)
16.2
Average true range (ATR 14)
0.1985
ATR as % of price
0.69%
Volatility compression (ATR14/ATR50)
0.91x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

DECU evidence rails

Atlas uses the specific public rails available for DECU: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on DECU

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for DECU Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep DECU research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

DECU FAQ

What is AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU)?AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. Use this page to check the price chart,...

AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for DECU?AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. It brings the latest available chart, company...

AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. DECU stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the DECU page updated?The DECU public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The DECU public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for DECU?The DECU file starts with Nasdaq Trader and TradingView BATS:DECU. The page separates verified market context from company evidence and shows open evidence gaps instead...

The DECU file starts with Nasdaq Trader and TradingView BATS:DECU. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on DECU?Yes. The workstation can open DECU, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open DECU, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this DECU page investment advice?No. The DECU page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The DECU page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →